Drug allergy and non-HIV immune reconstitution inflammatory syndrome.

Abstract

Non-HIV immune reconstitution inflammatory syndrome (non-HIV IRIS) is associated with the recovery from an immunocompromised condition. It is defined as inflammatory disorders caused by antigens, including drugs or pathogenic microorganisms present prior to immune recovery, or by the exacerbation of an inflammatory disorder that was already present. Drug-induced hypersensitivity syndrome is a prototype of IRIS, and the pathophysiology of non-HIV IRIS can be recognized in several disorders treated with corticosteroids, immunosuppressants, molecular-targeted drugs, TNF-α antibody drugs, immune checkpoint inhibitors, and dipeptidyl peptidase-4 inhibitors. This review focuses on the relationship between the immune mechanism of non-HIV IRIS and drug allergies, especially severe drug eruption. The antigen recognition mechanism in drug allergy varies depending on the clinical type and the causative drug. The p-i concept is the main mechanism in severe drug eruption such as Stevens-Johnson syndrome/toxic epidermal necrolysis, and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Lymphocytes activated by an antigen other than a drug, such as a virus, can also develop drug allergy by the loose binding of drugs with immune receptors of T cells or human leukocyte antigen. Therefore, fluctuations in the immune environment affect the onset of severe drug eruption. Novel agents that cause major changes in immunity have been marketed mainly for autoimmune diseases and malignant tumors; therefore, it is necessary to consider their effects when treating severe drug eruptions. Moreover, although a list of diagnostic criteria for this syndrome has been drafted, predictive and diagnostic biomarkers for this syndrome needs to be urgently developed.

• Authors: Hirohiko Sueki, Yuko Watanabe, Seiko Sugiyama, Yoshiko Mizukawa
• Journal: Allergology international : official journal of the Japanese Society of Allergology (Allergol Int) Vol. 71 Issue 2 Pg. 185-192 (Apr 2022) ISSN: 1440-1592 [Electronic] England
• PMID: 35236619 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2022 Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.

Chemical References

• Adrenal Cortex Hormones

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Drug Hypersensitivity Syndrome (diagnosis)
• Eosinophilia (drug therapy)
• Humans
• Immune Reconstitution Inflammatory Syndrome (complications, diagnosis)
• Stevens-Johnson Syndrome (diagnosis)